ARCHIVES

Matrisian, Nelson, to lead review of NCI translational research programs.

This article is from The Cancer Letter archive.

Vol. 31 No. 34 | September 23, 2005

Download PDF Visit The Full Archive

Related Articles

ASCO Highlights Seven of 4,000 Abstracts Submitted for Annual Meeting, June 3-7

May 27, 2011

HPV Can Affect Response To Radiation Therapies

September 28, 2012

Study Finds That CTC Was Used Correctly In Medicare Patients

April 26, 2013

Lederberg Appointment As Panel Chairman Confirmed; Bernard Fisher will Be Names To The Other Vacancy

November 30, 1979

Phase III Custirsen/Docetaxel/Prednisone Trial Fails Primary Endpoint of Overall Survival

April 25, 2014

Columbia Next for comprehensive Center Review

February 18, 1977